Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Dynamics Raises $30M

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Cellular Dynamics International said today it has closed on a Series B Preferred Stock financing round, raising $30 million.

The financing will be used by the Madison, Wis.-based pluripotent stem cell development firm to launch new iCell induced pluripotent stem cell lines, as well as iCell Endothelial Cells, iCell Neurons, and iCell Hepatocytes for biomedical and pharmaceutical drug development and safety research.

The funds also enable the company to increase production capacity for its iCell Cardiomyoctes, the first commercial product based on stem cells grown from adult tissue using CDI's iPSC technology.

CDI said it expects to expand its commercial operations to meet growing demand for its iPSC products.

The round was led by an entity affiliated with Tactics II Stem Cell Ventures, which along with its affiliates led CDI's earlier financing rounds. Also participating in the round was Sam Zell's Equity Group Investments, Sixth Floor Investors, and G Force Investments.

A year ago, CDI brought in $40.6 million in Series B private equity funding, and in total the company has raised $100 million since 2004.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.